Committee for Orphan Medicinal Products (COMP): 8-10 September 2020
Date:
08/09/2020 to 10/09/2020
Location:
Virtual meeting
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
COMP meeting report on the review of applications for orphan designation: September 2020 (PDF/275.53 KB)
Adopted
First published: 21/09/2020
EMA/COMP/479534/2020 -
List item
Agenda - COMP agenda of the 8-10 September 2020 meeting (PDF/313.32 KB)
Draft
First published: 08/09/2020
EMA/COMP/393282/2020